Laura E. Herring

5.0k total citations · 1 hit paper
100 papers, 2.9k citations indexed

About

Laura E. Herring is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Laura E. Herring has authored 100 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 18 papers in Immunology and 17 papers in Oncology. Recurrent topics in Laura E. Herring's work include Ubiquitin and proteasome pathways (16 papers), Protein Degradation and Inhibitors (12 papers) and interferon and immune responses (9 papers). Laura E. Herring is often cited by papers focused on Ubiquitin and proteasome pathways (16 papers), Protein Degradation and Inhibitors (12 papers) and interferon and immune responses (9 papers). Laura E. Herring collaborates with scholars based in United States, China and Netherlands. Laura E. Herring's co-authors include Longzhen Zhang, Andrew Z. Wang, Tian Zhang, Joseph M. Caster, Kyle C. Roche, Joel E. Tepper, Jonathan S. Serody, Shengjie Chai, Shaomin Tian and Joseph M. DeSimone and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Laura E. Herring

95 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

2017 590 citations Laura E. Herring et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura E. Herring United States	26	1.6k	796	616	560	263	100	2.9k
Alan Serrels United Kingdom	28	1.5k 0.9×	473 0.6×	740 1.2×	287 0.5×	192 0.7×	40	3.3k
Mohammad Hojjat‐Farsangi Sweden	36	1.8k 1.1×	1.3k 1.6×	1.1k 1.8×	432 0.8×	252 1.0×	139	4.0k
Jelena Vider United States	25	1.2k 0.7×	970 1.2×	930 1.5×	457 0.8×	140 0.5×	51	3.2k
Paul J. Yazaki United States	33	1.3k 0.8×	461 0.6×	1.1k 1.7×	369 0.7×	439 1.7×	102	3.4k
Annette R. Khaled United States	32	1.7k 1.1×	1.4k 1.8×	868 1.4×	244 0.4×	154 0.6×	73	3.6k
Kelly M. Stewart Canada	12	1.9k 1.2×	1.3k 1.6×	211 0.3×	281 0.5×	156 0.6×	15	3.4k
Moshe Elkabets Israel	25	1.4k 0.8×	1.2k 1.5×	1.1k 1.7×	220 0.4×	295 1.1×	84	3.0k
Hridayesh Prakash India	23	1.1k 0.7×	774 1.0×	727 1.2×	356 0.6×	266 1.0×	56	2.5k
Jan Brábek Czechia	29	1.4k 0.9×	277 0.3×	891 1.4×	402 0.7×	174 0.7×	85	3.1k
Daniel Rösel Czechia	28	1.2k 0.7×	262 0.3×	793 1.3×	393 0.7×	157 0.6×	70	2.7k

Countries citing papers authored by Laura E. Herring

Since Specialization

Citations

This map shows the geographic impact of Laura E. Herring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Herring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Herring more than expected).

Fields of papers citing papers by Laura E. Herring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Herring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Herring. The network helps show where Laura E. Herring may publish in the future.

Co-authorship network of co-authors of Laura E. Herring

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Herring. A scholar is included among the top collaborators of Laura E. Herring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Herring. Laura E. Herring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Zhichuan, Xin Zhou, Jianfeng Chen, et al.. (2025). Molecular glue degrader function of SPOP inhibitors enhances STING-dependent immunotherapy efficacy in melanoma models. Journal of Clinical Investigation. 135(24). 1 indexed citations

Khan, Abid, Cheng Zhang, Phu Hung Nguyen, et al.. (2025). A SETD2–CDK1–lamin axis maintains nuclear morphology and genome stability. Nature Cell Biology. 27(8). 1327–1341. 1 indexed citations

Parsons, Victoria A., Swarooparani Vadlamudi, Maren E. Cannon, et al.. (2025). TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin. Diabetologia. 68(6). 1169–1183. 1 indexed citations

Almond, Martha, Laura E. Herring, Julia E. Rager, et al.. (2025). Exploratory analysis of the impact of sex on sputum proteomic response to inhaled wood smoke in humans. Toxicological Sciences. 209(1).

Song, Feifei, Thomas S.K. Gilbert, Lee M. Graves, et al.. (2025). A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells. Nature Immunology. 26(2). 279–293. 5 indexed citations

Graboski, Amanda L., Joshua B. Simpson, Samuel J. Pellock, et al.. (2024). Advanced piperazine-containing inhibitors target microbial β-glucuronidases linked to gut toxicity. RSC Chemical Biology. 5(9). 853–865. 1 indexed citations

Matera, A. Gregory, et al.. (2024). Proteomic analysis of the SMN complex reveals conserved and etiologic connections to the proteostasis network. SHILAP Revista de lepidopterología. 2. 3 indexed citations

Ye, Michael, et al.. (2024). Developing forebrain synapses are uniquely vulnerable to sleep loss. Proceedings of the National Academy of Sciences. 121(44). e2407533121–e2407533121. 2 indexed citations

Dou, Zhangqi, Peishun Shou, Elisa Landoni, et al.. (2024). 4-1BB-encoding CAR causes cell death via sequestration of the ubiquitin-modifying enzyme A20. Cellular and Molecular Immunology. 21(8). 905–917. 14 indexed citations

10.

Carberry, Celeste K., Laura E. Herring, Yong Ho Kim, et al.. (2024). Wildfire-relevant woodsmoke and extracellular vesicles (EVs): Alterations in EV proteomic signatures involved in extracellular matrix degradation and tissue injury in airway organotypic models. Environmental Research. 264(Pt 2). 120395–120395.

11.

Risteski, Patrik, Yang Yang, Huan Chen, et al.. (2023). The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation. Nucleic Acids Research. 51(19). 10568–10589. 7 indexed citations

12.

Hanley, Ronan P., Yan Nie, Fengling Li, et al.. (2023). Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2. Journal of the American Chemical Society. 145(14). 8176–8188. 32 indexed citations

13.

Roell, Kyle R., Catherine M. Bulka, Karl Kuban, et al.. (2023). Prenatal Metal Exposure Alters the Placental Proteome in a Sex-Dependent Manner in Extremely Low Gestational Age Newborns: Links to Gestational Age. International Journal of Molecular Sciences. 24(19). 14977–14977. 2 indexed citations

14.

Wass, Amanda B., Benjamin A. Krishna, Laura E. Herring, et al.. (2022). Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latency. Science Advances. 8(43). eadd1168–eadd1168. 12 indexed citations

15.

Yu, Xufen, Jithesh Kottur, Yudao Shen, et al.. (2021). A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. Science Translational Medicine. 13(613). eabj1578–eabj1578. 91 indexed citations

16.

Liao, Chengheng, Yang Zhang, Cheng Fan, et al.. (2020). Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer. Cancer Discovery. 10(11). 1706–1721. 49 indexed citations

17.

Hu, Lianxin, Haibiao Xie, Xijuan Liu, et al.. (2019). TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss. Cancer Discovery. 10(3). 460–475. 72 indexed citations

18.

Zhu, Yi, George A. Howard, Laura E. Herring, et al.. (2019). Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA–NF-κB. Molecular Cancer Research. 17(9). 1910–1919. 17 indexed citations

19.

Herring, Laura E., Lauren Haar, Thomas S.K. Gilbert, et al.. (2018). Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma. Journal of Proteome Research. 18(1). 522–534. 6 indexed citations

20.

Kaltenbrun, Erin, Todd M. Greco, Brenda Temple, et al.. (2017). Formation of a TBX20-CASZ1 protein complex is protective against dilated cardiomyopathy and critical for cardiac homeostasis. PLoS Genetics. 13(9). e1007011–e1007011. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact